+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tamiflu"

From
From
H3N2 infection - Pipeline Insight, 2024 - Product Thumbnail Image

H3N2 infection - Pipeline Insight, 2024

  • Drug Pipelines
  • February 2024
  • 80 Pages
  • Global
From
Antiviral Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Antiviral Drugs Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
From
From
From
Tamiflu - API Insight, 2022 - Product Thumbnail Image

Tamiflu - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Antiviral Therapeutics - Technologies, Markets & Companies - Product Thumbnail Image

Antiviral Therapeutics - Technologies, Markets & Companies

  • Report
  • November 2021
  • 620 Pages
  • Global
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Tamiflu (oseltamivir) is an antiviral medication used to treat and prevent influenza (flu) caused by influenza A and B viruses. It is a neuraminidase inhibitor, which works by blocking the activity of the virus in the body. Tamiflu is approved for use in adults and children over the age of two weeks. It is available in capsule and liquid form. Tamiflu is one of the most widely used drugs for the treatment and prevention of influenza. It is used in both outpatient and inpatient settings, and is recommended by the Centers for Disease Control and Prevention (CDC) for the treatment of influenza. It is also used to reduce the risk of complications from influenza, such as pneumonia and hospitalization. Tamiflu is marketed by several pharmaceutical companies, including Roche, GlaxoSmithKline, and Sanofi. It is also available as a generic drug, which is manufactured by several generic drug companies. Tamiflu is available in many countries around the world, including the United States, Canada, Europe, and Asia. Show Less Read more